Cargando…
Adequacy and Effectiveness of Watson For Oncology in the Treatment of Thyroid Carcinoma
BACKGROUND: IBM’s Watson for Oncology (WFO) is an artificial intelligence tool that trains by acquiring data from the Memorial Sloan Kettering Cancer Center and learns from test cases and experts. This study aimed to analyze the adequacy and effectiveness of WFO in determining the treatment method f...
Autores principales: | Yun, Hyeok Jun, Kim, Hee Jun, Kim, Soo Young, Lee, Yong Sang, Lim, Chi Young, Chang, Hang-Seok, Park, Cheong Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968416/ https://www.ncbi.nlm.nih.gov/pubmed/33746898 http://dx.doi.org/10.3389/fendo.2021.585364 |
Ejemplares similares
-
Thyroid Hormone Supplementation Therapy for Differentiated Thyroid Cancer After Lobectomy: 5 Years of Follow-Up
por: Kim, Soo Young, et al.
Publicado: (2020) -
Lateral neck dissection for the treatment of synchronous and metachronous lateral neck metastasis of N1b papillary thyroid cancer
por: Yun, Hyeok Jun, et al.
Publicado: (2023) -
Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
por: Kim, Soo Young, et al.
Publicado: (2019) -
Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center
por: Kim, Sun Jung, et al.
Publicado: (2021) -
Survival With Lenvatinib for the Treatment of Progressive Anaplastic Thyroid Cancer: A Single-Center, Retrospective Analysis
por: Kim, Soo Young, et al.
Publicado: (2020)